Perineural Invasion is a Marker for Pathologically Advanced Disease in Localized Prostate Cancer

International Journal of Radiation Oncology Biology Physics

Volumn 68, Issue 4, 2007, Pages 1059-1064

  Lee, Irwin H ^a   Roberts, Rebecca ^a   Shah, Rajal B ^b   Wojno, Kirk J ^b   Wei, John T ^b   Sandler, Howard M ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Gleason score; Pathologic stage; Perineural invasion; Prostate cancer; Risk stratification

Indexed keywords

EXTRAPROSTATIC EXTENSION; GLEASON SCORE; PATHOLOGIC STAGE; PERINEURAL INVASION; PROSTATE CANCER; RISK STRATIFICATION;

ANTIGENS; BIOPSY; DATABASE SYSTEMS; ONCOLOGY; PATHOLOGY; TUMORS;

PATIENT TREATMENT;

PROSTATE SPECIFIC ANTIGEN;

ADULT; ADVANCED CANCER; ARTICLE; CANCER INVASION; CANCER LOCALIZATION; CANCER PATIENT; CANCER SURGERY; CONTROLLED STUDY; DATA BASE; DISEASE MARKER; DISEASE SEVERITY; GLEASON SCORE; HIGH RISK POPULATION; HUMAN; LYMPH NODE; MALE; PATHOLOGY; PERINEURAL INVASION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; PROSTATECTOMY; SEMINAL VESICLE;

HUMANS; LYMPHATIC METASTASIS; MALE; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROSPECTIVE STUDIES; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SEMINAL VESICLES;

EID: 34447252597     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.01.039     Document Type: Article

References (24)

1. Symon Z., Griffith K.A., McLaughlin P.W., et al. Dose escalation for localized prostate cancer: Substantial benefit observed with 3D conformal therapy. Int J Radiat Oncol Biol Phys 57 (2003) 384-390
2. D'Amico A.V., Whittington R., Malkowicz S.B., et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280 (1998) 969-974
3. Nag S., Beyer D., Friedland J., et al. American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer. Int J Radiat Oncol Biol Phys 44 (1999) 789-799
4. Pollack A., Zagars G.K., Starkschall G., et al. Prostate cancer radiation dose response: Results of the M. D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 53 (2002) 1097-1105
5. Roach III M., DeSilvio M., Lawton C., et al. Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413. J Clin Oncol 21 (2003) 1904-1911
6. D'Amico A.V., Manola J., Loffredo M., et al. 6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: A randomized controlled trial. JAMA 292 (2004) 821-827
7. Bolla M., Collette L., Blank L., et al. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): A phase III randomised trial. Lancet 360 (2002) 103-106
8. Hanks G.E., Pajak T.F., Porter A., et al. Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: The Radiation Therapy Oncology Group Protocol 92-02. J Clin Oncol 21 (2003) 3972-3978
9. Egevad L., Norlen B.J., and Norberg M. The value of multiple core biopsies for predicting the Gleason score of prostate cancer. BJU Int 88 (2001) 716-721
10. Coogan C.L., Latchamsetty K.C., Greenfield J., et al. Increasing the number of biopsy cores improves the concordance of biopsy Gleason score to prostatectomy Gleason score. BJU Int 96 (2005) 324-327
11. Grossfeld G.D., Chang J.J., Broering J.M., et al. Under staging and under grading in a contemporary series of patients undergoing radical prostatectomy: Results from the Cancer of the Prostate Strategic Urologic Research Endeavor database. J Urol 165 (2001) 851-856
12. Han M., Partin A.W., Zahurak M., et al. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. J Urol 169 (2003) 517-523
13. de la Taille A., Katz A., Bagiella E., et al. Perineural invasion on prostate needle biopsy: An independent predictor of final pathologic stage. Urology 54 (1999) 1039-1043
14. Rubin M.A., Mucci N.R., Manley S., et al. Predictors of Gleason pattern 4/5 prostate cancer on prostatectomy specimens: Can high grade tumor be predicted preoperatively?. J Urol 165 (2001) 114-118
15. Weight C.J., Ciezki J.P., Reddy C.A., et al. Perineural invasion on prostate needle biopsy does not predict biochemical failure following brachytherapy for prostate cancer. Int J Radiat Oncol Biol Phys 65 (2006) 347-350
16. Merrick G.S., Butler W.M., Wallner K.E., et al. Prognostic significance of perineural invasion on biochemical progression-free survival after prostate brachytherapy. Urology 66 (2005) 1048-1053
17. Beard C.J., Chen M.H., Cote K., et al. Perineural invasion is associated with increased relapse after external beam radiotherapy for men with low-risk prostate cancer and may be a marker for occult, high-grade cancer. Int J Radiat Oncol Biol Phys 58 (2004) 19-24
18. Beard C., Schultz D., Loffredo M., et al. Perineural invasion associated with increased cancer-specific mortality after external beam radiation therapy for men with low- and intermediate-risk prostate cancer. Int J Radiat Oncol Biol Phys 66 (2006) 403-407
19. Villers A., McNeal J.E., Redwine E.A., et al. The role of perineural space invasion in the local spread of prostatic adenocarcinoma. J Urol 142 (1989) 763-768
20. Ayala G.E., Dai H., Ittmann M., et al. Growth and survival mechanisms associated with perineural invasion in prostate cancer. Cancer Res 64 (2004) 6082-6090
21. Wong W.W., Schild S.E., Vora S.A., et al. Association of percent positive prostate biopsies and perineural invasion with biochemical outcome after external beam radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 60 (2004) 24-29
22. Wheeler T.M., Dillioglugil O., Kattan M.W., et al. Clinical and pathological significance of the level and extent of capsular invasion in clinical stage T1-2 prostate cancer. Hum Pathol 29 (1998) 856-862
23. Bolla M., van Poppel H., Collette L., et al. Postoperative radiotherapy after radical prostatectomy: A randomised controlled trial (EORTC trial 22911). Lancet 366 (2005) 572-578
24. Thompson Jr. I.M., Tangen C.M., Paradelo J., et al. Adjuvant radiotherapy for pathologically advanced prostate cancer: A randomized clinical trial. JAMA 296 (2006) 2329-2335